Sign in to follow
Search Results

0 results for ''McDonnell Boehnen Hulbert''

You can use to get even better search results
November 01, 2004 |

IP Blog Roundup

With their immediacy and focus, blogs are becoming de rigueur in legal circles. And that's more the case for intellectual property than it is for any other practice area. Dozens of blogs now track developments in patent, trademark and copyright law. Written by practicing lawyers, full-time academics and even non-lawyers, they discuss events virtually as they happen, often adding unique perspective and analysis. Here is a survey of selected IP blogs.
6 minute read
March 23, 2006 |

Firm Builds on Delaware Base for Patent Case Wins

When Pfizer GC Jeffrey Kindler faced a challenge to the patents on its blockbuster drug Lipitor, he went with Delaware's Connolly Bove Lodge & Hutz -- a relatively small IP firm -- instead of a big-name, mega-lawyer firm in its stable of outside counsel. The move paid off with a judgment in Pfizer's favor. And the win couldn't have come at a better time for Connolly Bove, which was getting ready to open its second satellite office in Los Angeles and start prospecting for work out West.
10 minute read
October 25, 2004 |

Intellectual Property Blogs

With their immediacy and focus, blogs provide up-to-the-minute news and analysis of judicial, legislative and regulatory developments. More than in any other area of law, this is the case for intellectual property.
6 minute read
May 29, 2001 |

Patent Thyself

After learning their children were congenitally ill, a Massachusetts couple become unlikely power brokers on the frontiers of intellectual property: They claim they own their own bodies. Necessity inspired them to create a device that gives patients control over the intellectual property at the center of disease research. Their tool? Do-it-yourself patenting. Or, literally, patenting yourself.
14 minute read
Sanofi, Albany Molecular Win Preliminary Injunction Blocking Dr. Reddy's Generic Version of Allegra
Publication Date: 2010-06-15
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

At risk drug launches, in which a generic manufacturer launches its version of a brand-name drug without a finding that the brand manufacturer's patent is invalid or not infringed, amount to a high-stakes game of chicken by the generic. They're rarely attempted--and the fate of Dr. Reddy's version of Allegra-D shows why.

Schering Corporation v. Amgen, Inc.
Publication Date: 2000-08-03
Practice Area: patents
Industry:
Court: Fed. Cir.
Judge: RADER, Circuit Judge, ARCHER, Senior Circuit Judge, and GAJARSA, Circuit Judge
Attorneys:
For plaintiff: Gerald Sobel et al.
For defendant: Daniel A. Boehnen et al.
Case number: No. 99-1251

The full case caption appears at the end of this opinion. RADER, Circuit Judge. Schering Corporation and Biogen, Inc. (collectively, Schering) sued Amgen Inc. in the United

Reiffin v. Microsoft Corporation
Publication Date: 2000-06-08
Practice Area: cyber ip | patents
Industry:
Court: Fed. Cir.
Judge: NEWMAN, MICHEL, and SCHALL, Circuit Judges
Attorneys:
For plaintiff: Martin G. Reiffin
For defendant: John D. Vandenberg
Case number: No. 98-1502

The full case caption appears at the end of this opinion.OPINION PER CURIAM, JUDGE NEWMAN CONCURS IN THE JUDGMENT WITH OPINION. Martin Gardner Reiffin appe

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • Corporate Transparency Act Resource Kit

      Brought to you by Wolters Kluwer

      Download Now

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now